Press Releases for MDT

Press Releases
PicksThatMove.com Announces Investment Opinion on Lundin Mining Corporation, Medtronic Inc., Origin Agritech Limited, NovaGold Resources Inc. and Mass Petroleum Inc.
Medtronic Chairman and CEO Bill HawkinsProvides Statement on U.S. Senate's Revised Medical Device Industry Fee Proposal
Medtronic Receives President's "E" Award in Recognition of Its Support of U.S. Exports
RidgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on MGM, MDT, MO, MENT, ONXX and WFMI
Physio-Control Receives Market Approval From Health Canada for LIFEPAK® 15 Monitor/Defibrillator
Medtronic and W.L. Gore & Associates Settle Patent Dispute
Medtronic Board Approves Second Quarter Cash Dividend for Fiscal Year 2010
Medtronic Reports First Quarter Revenue of $3.9 Billion
Surgeon accused of faking study resigns
Medtronic to Announce Financial Results for Its First Fiscal Quarter
BenchmarkJournal.Com Free Analyst Review for AGU, CSX, EQT, HIW, MDT and FPL
Medtronic Awarded $57 Million in Patent Dispute With AGA Medical Corporation
Medtronic Appoints D. Cameron Findlay to Serve as Senior Vice President, General Counsel and Corporate Secretary
Skyline Ventures Names Glenn Reicin Managing Director, Expands Investment Team
Medtronic and Abbott Laboratories Resolve Global Vascular Patent Disputes
FDA Classifies Medtronic Voluntary February Recall for Intrepid™ Intervertebral Body Fusion Device as Class II
Economic Outlook: Conscious Capitalism
FDA Panel Recommends Approval of Medtronic Heart Valve under Humanitarian Device Exemption
Signostics Closes Follow-On Financing of US$4 Million, Expands Board of Directors
Clinical Registry Begins Collecting Data on Industry’s Only Pacing Systems Approved for Use in MRI Machines
Medtronic Files Pre-Market Approval Application for FDA Approval of Deep Brain Stimulation for Treatment-Resistant Epilepsy
Medtronic Clinical Trial Evaluating the Industry’s First Cryoballoon Technology Designed for Paroxysmal Atrial Fibrillation Completes Follow Up
World's First Deep Brain Stimulation Device Approved for Treatment of Psychiatric Condition in Europe
Medtronic recalls insulin infusion pumps
Medtronic Voluntarily Recalls Specific Lots of Paradigm® Quick-Set® Infusion Sets in the United States
McKool Smith Announces Additions in Washington, D.C.
Study: Drug raises cost of surgery
Venture-Backed Exit Market Shows Signs of Life in Second Quarter
FDA Grants LUCAS™ 2 Chest Compression System 510(k) Clearance in the United States
Medtronic Announces Two Worldwide Clinical Trials to Study Medical Device Interventions for Stroke
Study Shows Medtronic Microdebrider Turbinoplasty is a Significantly More Effective, Long-Term Treatment Than Coblation® Radiofrequency for Nasal Obstructions1
New Data Proves Effectiveness of Medtronic Insertable Cardiac Monitor in Detecting AF, Most Common Heart Rhythm Disorder
MORE-CARE Trial to Assess Remote Monitoring Impact on Heart Failure Patients and Healthcare Utilization
Medtronic CFO Gary Ellis to Speak at 19th Annual Wachovia Equity Conference
Medtronic Receives CE Mark for Second-Generation MRI Pacemaker
Medtronic Board Increases Cash Dividend and Approves Share Repurchase Plan
McKool Smith Principals Earn Selection to Prestigious Chambers USA Listing
Consultant accused of false spine study
Acacia Subsidiary Enters into License Agreement With Medtronic, Inc.
Talent Stent Graft Shows Durable Performance in Patients with Abdominal Aortic Aneurysms
Physio-Control Named a Medical Device Excellence Award Winner
Medtronic pacemaker recall announced
Medtronic Receives FDA Approval For BRYAN® Cervical Disc System
Medtronic Foundation Announces $1.4 Million Grant to Teach For America
FDA Classifies Previously Announced Medtronic Physician Advisory on Small Subset of Kappa and Sigma Pacemakers as Class I Recall
HighJump Software Appoints Patrick Spangler As Chief Financial Officer
McKool Smith Adds Five Litigators in Growing New York Office
Study Shows Consistent Use of Insulin Pump Therapy, Augmented with Continuous Glucose Monitoring, Results in Significant A1C Reductions
Medtronic Highlights New Advances in Development of Closed-Loop System for Diabetes Management
BetterInvesting Magazine Releases August Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use
McKool Smith Builds Patent, Commercial Litigation Expertise With Latest Addition in Washington DC
Innovative Belfast-Based Company Appoints Internationally Renowned Scientist and Business Leader As Chairman
Medtronic CFO Gary Ellis to Speak at 29th Annual William Blair Growth Stock Conference
Medtronic's CoreValve Shows Subclavian Access Success in Patients Contraindicated for Femoral Approach
Medtronic to Reduce Global Workforce
Medtronic Annual Revenue Up 8 Percent to $14.6 Billion
Texas Life Sciences Industry Poised for Greater Growth
Medtronic Annual Meeting Date Scheduled for August 27, 2009
Medtronic and Johnson and Johnson Reach Agreement on Royalty Disputes
Video: Davis Phinney Foundation and Medtronic Raise Awareness of How to Improve Your Life Today for Those Living With Parkinson's Disease
Medtronic Completes Acquisition of CoreValve Inc.
Davis Phinney Foundation and Medtronic Raise Awareness of How to Improve Your Life Today for Those Living with Parkinson’s Disease
Medtronic Initiates Global Abdominal Aortic Aneurysm Study
Michael DeMane Joins Thomas, McNerney & Partners As Senior Advisor
Research and Markets: Menarini Group - The Complete Strategic Analysis Review of This Biopharmaceutical Company
Medtronic Announces International Market Release of Driver Sprint RX Coronary Stent System
New Data Presented at ACC.09 Shows Benefit of Cardiac Resynchronization Therapy in Mildly Symptomatic Heart Failure Patients
Results from Medtronic-Supported Clinical Trial Assessing Use of Implantable Cardiac Devices in Certain Heart Attack Patients Show Reduction in Sudden Cardiac Death
Medtronic Commends U.S. House Passage and Senate Introduction of National Pain Care Policy Act to Address Barriers to and Solutions for Effective Pain Management
Medtronic’s Endeavor Stent Shows Consistent and Sustained Safety and Effectiveness Benefits at Two Years
Thrombus Aspiration with Medtronic’s Export Catheter May Improve Outcomes for Heart Attack Patients
Clinical Data on Medtronic’s Cardiovascular Innovations to Feature Prominently at U.S. Cardiology Meeting
FDA Classifies Medtronic Voluntary February Recall for BioGlide® Ventricular Snap Shunt Catheters (Models 27782, 27708 and 27802) as Class I
Physio-Control Receives FDA 510(k) Clearance for LIFEPAK® 15 Monitor/Defibrillator
Ardian Completes $47 Million Financing Led by Medtronic to Develop Hypertension Treatment
Clinical Trial Exploring Use of Cardiac Device in New Groups of Heart Failure Patients Completes Enrollment Phase
Los Angeles Attorney Marc Marmaro Inducted into American College of Trial Lawyers
Research and Markets: Keep Abreast of Spain's Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015
Research and Markets: China Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015 Out Now
Suit Against Medtronic is Dismissed
Medtronic CFO Gary Ellis to Speak at 29th Annual Cowen Healthcare Conference
Medtronic Announces Public Offering of $1.25 Billion of Senior Notes
Largest Study on Balloon Kyphoplasty Demonstrates Superior Benefits Compared to Non-Surgical Care in Treating Vertebral Compression Fractures
Medtronic to Voluntarily Disclose Payments To U.S. Physicians
CoreValve to be acquired by Medtronic for $700+ million
Medtronic Acquires Ventor Technologies Ltd.
Medtronic to Acquire CoreValve, Inc.
Medtronic Receives FDA HDE Approval to Commercialize the First Deep Brain Stimulation (DBS) Therapy for a Psychiatric Indication in the United States
Medtronic Board Approves Fourth Quarter Cash Dividend
Medtronic Reports Third Quarter Revenue of $3.5 Billion
First Use of New Subcutaneous Heart Monitor
Given Imaging Reports Fourth Quarter and Full-Year 2008 Results
Medtronic to Announce Financial Results for Its Third Fiscal Quarter
BenchmarkJournal.Com (Complimentary) Analyst Review for MDT, GGB, PAAS and SOLR
Medtronic Completes Acquisition of Ablation Frontiers
Medtronic Applauds Introduction of the National Pain Care Policy Act to Address Therapy Access for Patients
Medtronic Completes Enrollment in Global Head-to-Head Stent-Safety Study
Brower Piven Informs Shareholders Who Have Losses in Excess of $250,000 From Investment in Medtronic, Inc. That Only 12 Days Remain Until Deadline to Move for Appointment as Lead Plaintiff in Securities Class Action Lawsuit
Medtronic Expands CURE-AF Clinical Program into Europe and Canada
Medtronic and Boston Scientific Reach Agreement on Patent Cases